Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas

Journal of Oral Pathology and Medicine

Volumn 43, Issue 9, 2014, Pages 652-657

  Paluszczak, Jaroslaw ^a   Hemmerling, Dawid ^a   Kostrzewska Poczekaj, Magdalena ^b   Jarmuz Szymczak, Malgorzata ^b   Grenman, Reidar ^c   Wierzbicka, Malgorzata ^a   Baer Dubowska, Wanda ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF HUMAN GENETICS   (Poland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

DNA methylation; Epimarker; Laryngeal cancer; WNT pathway

Indexed keywords

CALCINEURIN; DICKKOPF 1 PROTEIN; PROTEIN; PROTEIN KINASE LKB1; SECRETED FRIZZLED RELATED PROTEIN 1; SECRETED FRIZZLED RELATED PROTEIN 2; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG; WIF 1 PROTEIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; HUMAN; LARYNX SQUAMOUS CELL CARCINOMA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; PROMOTER REGION; TUMOR RECURRENCE; WNT SIGNALING PATHWAY;

EID: 84914180346     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12178     Document Type: Article

References (41)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Leemans CR, Braakhuis BJM, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11: 9-22.
3. Paluszczak J, Baer-Dubowska W. Epigenetic diagnostics of cancer - the application of DNA methylation markers. J Appl Genet 2006; 47: 365-75.
4. Reya T, Clevers H. WNT signaling in stem cells and cancer. Nature 2005; 434: 843-50.
5. Molinolo AA, Amornphimoltham P, Squarize CH, Castilho RM, Patel V, Gutkind JS. Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol 2009; 45: 324-34.
6. Leethanakul C, Patel V, Gillespie J, et al. Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene 2000; 19: 3220-4.
7. Baker H, Patel V, Molinolo AA, et al. Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry. Oral Oncol 2005; 41: 183-99.
8. Worsham MJ, Chen KM, Meduri V, et al. Epigenetic events of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2006; 132: 668-77.
9. Chang KW, Lin SC, Mangold KA, et al. Alterations of adenomatous polyposis Coli (APC) gene in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2000; 29: 223-6.
10. Pannone G, Bufo P, Santoro A, et al. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors. Oncol Rep 2010; 24: 1035-41.
11. Liu JB, Qiang FL, Dong J, et al. Plasma DNA methylation of WNT antagonists predicts recurrence of esophageal squamous cell carcinoma. World J Gastroenterol 2011; 17: 4917-21.
12. Giefing M, Martin-Subero JI, Kiwerska K, et al. Characterization of homozygous deletions in laryngeal squamous cell carcinoma cell lines. Cancer Genet Cytogenet 2008; 184: 38-43.
13. Jarmuz M, Golusiński W, Grenman R, Szyfter K. Analysis of chromosome aberrations in cell lines derived from laryngeal cancer in relation to tumor progression. Eur Arch Otorhinolaryngol 2002; 259: 269-73.
14. Jarmuz M, Grenman R, Golusiński W, Szyfter K. Aberrations of 11q13 in laryngeal squamous cell lines and their prognostic significance. Cancer Genet Cytogenet 2005; 160: 82-8.
15. Jarmuz-Szymczak M, Pelinska K, Kostrzewska-Poczekaj M, et al. Heterogeneity of 11q13 region rearrangements in laryngeal squamous cell carcinoma analyzed by microarray platforms and fluorescence in situ hybridization. Mol Biol Rep 2013; 40: 4161-71.
16. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-6.
17. Song HJ, Shim KN, Joo YH, Kim SE, Jung SA, Yoo K. Methylation of the tumor suppressor gene RUNX3 in human gastric carcinoma. Gut Liver 2008; 2: 119-25.
18. Esteller M, Avizienyte E, Corn PG, et al. Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene 2000; 19: 164-8.
19. Sogabe Y, Suzuki H, Toyota M, et al. Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma. Int J Oncol 2008; 32: 1253-61.
20. Tan J, Lee PL, Li Z, et al. B55β-associated PP2A complex controls PDK1-directed myc signaling and modulates rapamycin sensitivity in colorectal cancer. Cancer Cell 2010; 18: 459-71.
21. Dhir M, Montgomery EA, Glöckner SC, et al. Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia. J Gastrointest Surg 2008; 12: 1745-53.
22. Gao F, Huang C, Lin M, et al. Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomas. J Cancer Res Clin Oncol 2009; 135: 739-47.
23. Supic G, Kozomara R, Jovic N, Zeljic K, Magic Z. Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers. Oral Dis 2011; 17: 794-800.
24. Chan SL, Cui Y, Van Hasselt A, et al. The tumor suppressor WNT inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas. Lab Invest 2007; 87: 644-50.
25. Lin YC, You L, Xu Z, et al. WNT signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines. Biochem Biophys Res Commun 2006; 341: 635-40.
26. Fendri A, Khabir A, Hadri-guiga B, et al. Epigenetic alteration of the WNT inhibitory factor-1 promoter is common and occurs in advanced stage of Tunisian nasopharyngeal carcinoma. Cancer Invest 2010; 28: 896-903.
27. Tang J, Bai W, Ji W, Gao H, Liu J. Relationship between hypermethylation of Runx3 gene and the development and metastasis of laryngeal carcinoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2010; 24: 834-7.
28. Chen RW, Avizienyte E, Roth S, et al. PTEN and LKB1 genes in laryngeal tumours. J Med Genet 1999; 36: 943-4.
29. Qiu W, Schnleben F, Thaker HM, Goggins M, Ugh S. A novel mutation of STK11/LKB1 gene leads to the loss of cell growth inhibition in head and neck squamous cell carcinoma. Oncogene 2006; 25: 2937-42.
30. Ekizoglu S, Dalay N, Karaman E, Akdeniz D, Ozaydin A, Buyru N. LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer. Transl Res 2013; 162: 122-9.
31. Kline ER, Muller S, Pan L, Tighiouart M, Chen ZG, Marcus AI. Localization-specific LKB1 loss in head and neck squamous cell carcinoma metastasis. Head Neck 2011; 33: 1501-12.
32. Kudo Y, Tsunematsu T, Takata T. Oncogenic role of RUNX3 in head and neck cancer. J Cell Biochem 2011; 112: 387-93.
33. Marsit CJ, Mcclean MD, Furniss CS, Kelsey KT. Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma. Int J Cancer 2006; 119: 1761-6.
34. Katase N, Gunduz M, Beder LB, et al. Frequent allelic loss of Dkk-1 locus (10q11.2) is related with low distant metastasis and better prognosis in head and neck squamous cell carcinomas. Cancer Invest 2010; 28: 103-10.
35. Bockelman C, Hagstrom J, Makinen LK, et al. High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer. Br J Cancer 2011; 104: 1890-5.
36. Katz J, Jakymiw A, Ducksworth MK, et al. CIP2A expression and localization in oral carcinoma and dysplasia. Cancer Biol Ther 2010; 10: 694-9.
37. Basile JR, Czerninski R. The role of CIP2A in oral squamous cell carcinoma. Cancer Biol Ther 2010; 10: 700-2.
38. Perrotti D, Neviani P. Protein phosphatase 2A: a target for anticancer therapy. Lancet Oncol 2013; 14: e229-38.
39. Paluszczak J, Misiak P, Wierzbicka M, Woźniak A, Baer-Dubowska W. Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa. Oral Oncol 2011; 47: 104-7.
40. Chang HW, Lee YS, Nam HY, et al. Knockdown of β-catenin controls both apoptotic and autophagic cell death through LKB1/AMPK signaling in head and neck squamous cell carcinoma cell lines. Cell Signal 2013; 25: 839-47.
41. Lim YC, Kang HJ, Kim YS, Choi EC. All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of WNT/β-catenin pathway. Eur J Cancer 2012; 48: 3310-8.